PL296038A1 - Method of obtaining biosynthesis inhibitors effective in respect to biosynthesis of leucotrienes - Google Patents
Method of obtaining biosynthesis inhibitors effective in respect to biosynthesis of leucotrienesInfo
- Publication number
- PL296038A1 PL296038A1 PL29603892A PL29603892A PL296038A1 PL 296038 A1 PL296038 A1 PL 296038A1 PL 29603892 A PL29603892 A PL 29603892A PL 29603892 A PL29603892 A PL 29603892A PL 296038 A1 PL296038 A1 PL 296038A1
- Authority
- PL
- Poland
- Prior art keywords
- biosynthesis
- leucotrienes
- obtaining
- respect
- inhibitors effective
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 2
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76459191A | 1991-09-24 | 1991-09-24 | |
| US07/937,315 US5296486A (en) | 1991-09-24 | 1992-09-04 | Leukotriene biosynthesis inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL296038A1 true PL296038A1 (en) | 1993-10-18 |
Family
ID=27117489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL29603892A PL296038A1 (en) | 1991-09-24 | 1992-09-24 | Method of obtaining biosynthesis inhibitors effective in respect to biosynthesis of leucotrienes |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5296486A (hu) |
| EP (1) | EP0535521A3 (hu) |
| JP (1) | JPH05213911A (hu) |
| KR (1) | KR930005992A (hu) |
| AU (1) | AU661034B2 (hu) |
| CA (1) | CA2078810A1 (hu) |
| CZ (1) | CZ293392A3 (hu) |
| FI (1) | FI924277A (hu) |
| HU (2) | HU213113B (hu) |
| IL (1) | IL103251A (hu) |
| LV (1) | LV11181B (hu) |
| MX (1) | MX9205432A (hu) |
| NO (1) | NO923695L (hu) |
| NZ (1) | NZ244429A (hu) |
| PL (1) | PL296038A1 (hu) |
| RU (1) | RU2080321C1 (hu) |
| SG (1) | SG46381A1 (hu) |
| SK (1) | SK293392A3 (hu) |
| TW (1) | TW218877B (hu) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698550A (en) * | 1993-06-14 | 1997-12-16 | Pfizer Inc. | Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases |
| CO4520280A1 (es) * | 1993-10-26 | 1997-10-15 | Boehringer Ingelheim Pharma | Derivados de pirrolidina, inhibidores de la bioscientesis de leucotrienos |
| DE4428531A1 (de) * | 1994-08-12 | 1996-02-15 | Boehringer Ingelheim Kg | Neue enantiomerenreine Pyridylcycloalkylethylamine und deren Salze sowie Verfahren zu ihrer Herstellung |
| US5616717A (en) * | 1995-04-20 | 1997-04-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process for the preparation of pure enantiomers of 1-(2-pyridyl)-2-cyclohexylethylamine |
| US5856497A (en) | 1995-12-11 | 1999-01-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Asymmetric synthesis of α-cycloalkylalkyl substituted methanamines |
| AU744281B2 (en) | 1997-11-10 | 2002-02-21 | Bristol-Myers Squibb Company | Benzothiazole protein tyrosine kinase inhibitors |
| US5952326A (en) * | 1997-12-10 | 1999-09-14 | Pfizer Inc. | Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| EP1056714B1 (en) * | 1998-02-26 | 2004-08-11 | Celltech Therapeutics Limited | Phenylalanine derivatives as inhibitors of alpha4 integrins |
| GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9811969D0 (en) * | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9812088D0 (en) | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821061D0 (en) * | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| US6800486B1 (en) | 1998-12-07 | 2004-10-05 | Smithkline Beecham Corporation | Method for quantitative determination of amino acids |
| WO2000034251A1 (en) * | 1998-12-07 | 2000-06-15 | Smithkline Beecham Corporation | A method for quantitative determination of amino acids |
| CA2359112A1 (en) * | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| ES2339738T3 (es) | 1999-01-22 | 2010-05-25 | Elan Pharmaceuticals, Inc. | Derivados de acilo los cuales tratan trastornos relacionados con vla-4. |
| US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| AU3487500A (en) * | 1999-02-08 | 2000-08-25 | Lion Bioscience Ag | Thiazole derivatives and combinatorial libraries thereof |
| US6518283B1 (en) * | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
| US6436977B1 (en) | 1999-09-29 | 2002-08-20 | Pfizer Inc. | Dosing regimens for lasofoxifene |
| US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
| US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
| ATE375330T1 (de) | 2000-04-17 | 2007-10-15 | Ucb Pharma Sa | Enamin-derivate als zell-adhäsionsmoleküle |
| FR2808798A1 (fr) * | 2000-05-09 | 2001-11-16 | Hoechst Marion Roussel Inc | Nouveaux derives antagonistes du recepteur de la vitronectine |
| US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
| US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
| WO2002004426A1 (en) | 2000-07-07 | 2002-01-17 | Celltech R & D Limited | Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| EP1305291A1 (en) | 2000-08-02 | 2003-05-02 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
| ATE375983T1 (de) | 2000-12-15 | 2007-11-15 | Vertex Pharma | Bakterielle gyrase-hemmer und deren verwendung |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| SE0202429D0 (sv) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel Compounds |
| PL371841A1 (pl) * | 2004-12-20 | 2006-06-26 | ADAMED Sp.z o.o. | Nowe związki pochodne kwasu 3-fenylopropionowego |
| PL372332A1 (pl) * | 2005-01-19 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| PL372356A1 (pl) * | 2005-01-20 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| NZ567270A (en) | 2005-09-29 | 2011-06-30 | Elan Pharm Inc | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| CA2851103A1 (en) | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| KR20080100271A (ko) | 2006-02-27 | 2008-11-14 | 엘란 파마슈티칼스, 인크. | Ｖｌａ-4에 의해 매개되는 백혈구 부착을 억제하는 피리미디닐 술폰아미드 화합물 |
| BRPI0713656A2 (pt) * | 2006-06-30 | 2012-10-23 | Basf Se | compostos, composição veterinária ou agrìcola, métodos para combater pestes animais, e para proteger sementes contra insetos de solo e brotos e raìzes de mudas contra insetos, e, semente |
| WO2009126635A1 (en) * | 2008-04-09 | 2009-10-15 | Abbott Laboratories | 2-amino-benzothiazole derivates useful as inhibitors of rock kinases |
| DK2336125T3 (da) * | 2008-04-11 | 2013-04-08 | Janssen Pharmaceutica Nv | Thiazolopyridin-2-yloxy-phenyl- og thioazolopyrazin-2-yloxy-phenyl-aminer som modulatorer af leukotrien-A4-hydrolase |
| PL2367794T3 (pl) | 2008-11-24 | 2013-06-28 | Basf Se | Utwardzalna kompozycja zawierająca aktywowaną termicznie utajoną zasadę |
| EP2424841A1 (en) | 2009-04-27 | 2012-03-07 | Elan Pharmaceuticals Inc. | Pyridinone antagonists of alpha-4 integrins |
| WO2014195230A1 (de) | 2013-06-03 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Substituierte benzoxazole |
| UY35592A (es) * | 2013-06-03 | 2014-12-31 | Bayer Pharma AG | Benzoxazoles sustituidos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3419994A1 (de) * | 1984-05-29 | 1985-12-05 | Hoechst Ag, 6230 Frankfurt | Benzoxazolyl- und benzthiazolyl-aminosaeuren, ihre herstellung und verwendung im pflanzenschutz |
| DE3533331A1 (de) * | 1985-09-18 | 1987-03-26 | Heumann Ludwig & Co Gmbh | Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US4873346A (en) * | 1985-09-20 | 1989-10-10 | The Upjohn Company | Substituted benzothiazoles, benzimidazoles, and benzoxazoles |
| FI91859C (fi) * | 1987-06-17 | 1994-08-25 | Eisai Co Ltd | Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi |
| AU653349B2 (en) * | 1990-07-24 | 1994-09-29 | Agilent Technologies Australia (M) Pty Ltd | Inductively coupled plasma spectroscopy |
| IE920921A1 (en) * | 1991-04-04 | 1992-10-07 | Eisai Co Ltd | Benzothiazole derivative |
-
1992
- 1992-09-04 US US07/937,315 patent/US5296486A/en not_active Expired - Lifetime
- 1992-09-22 CA CA002078810A patent/CA2078810A1/en not_active Abandoned
- 1992-09-23 NZ NZ244429A patent/NZ244429A/en unknown
- 1992-09-23 HU HU9203033A patent/HU213113B/hu not_active IP Right Cessation
- 1992-09-23 IL IL10325192A patent/IL103251A/en not_active IP Right Cessation
- 1992-09-23 AU AU25274/92A patent/AU661034B2/en not_active Ceased
- 1992-09-23 NO NO92923695A patent/NO923695L/no unknown
- 1992-09-23 EP EP19920116249 patent/EP0535521A3/en not_active Withdrawn
- 1992-09-23 SG SG1996003973A patent/SG46381A1/en unknown
- 1992-09-23 RU SU925052823A patent/RU2080321C1/ru active
- 1992-09-24 SK SK2933-92A patent/SK293392A3/sk unknown
- 1992-09-24 LV LVP-92-133A patent/LV11181B/en unknown
- 1992-09-24 JP JP4255123A patent/JPH05213911A/ja active Pending
- 1992-09-24 PL PL29603892A patent/PL296038A1/xx unknown
- 1992-09-24 MX MX9205432A patent/MX9205432A/es unknown
- 1992-09-24 FI FI924277A patent/FI924277A/fi not_active Application Discontinuation
- 1992-09-24 KR KR1019920017495A patent/KR930005992A/ko not_active Application Discontinuation
- 1992-09-24 CZ CS922933A patent/CZ293392A3/cs unknown
- 1992-09-24 TW TW081107568A patent/TW218877B/zh active
-
1995
- 1995-04-06 US US08/417,547 patent/US5552421A/en not_active Expired - Fee Related
- 1995-04-12 HU HU95P/P00102P patent/HU210881A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2078810A1 (en) | 1993-03-25 |
| US5296486A (en) | 1994-03-22 |
| HU210881A9 (en) | 1995-09-28 |
| NO923695L (no) | 1993-03-25 |
| KR930005992A (ko) | 1993-04-20 |
| JPH05213911A (ja) | 1993-08-24 |
| LV11181A (lv) | 1996-04-20 |
| HU9203033D0 (en) | 1992-12-28 |
| MX9205432A (es) | 1993-03-31 |
| EP0535521A3 (en) | 1993-06-16 |
| HU213113B (en) | 1997-02-28 |
| RU2080321C1 (ru) | 1997-05-27 |
| FI924277A0 (fi) | 1992-09-24 |
| HUT64951A (en) | 1994-03-28 |
| LV11181B (en) | 1996-08-20 |
| EP0535521A2 (en) | 1993-04-07 |
| NZ244429A (en) | 1995-07-26 |
| AU661034B2 (en) | 1995-07-13 |
| AU2527492A (en) | 1993-03-25 |
| US5552421A (en) | 1996-09-03 |
| TW218877B (hu) | 1994-01-11 |
| SK293392A3 (en) | 1995-09-13 |
| SG46381A1 (en) | 1998-02-20 |
| IL103251A (en) | 1996-09-12 |
| CZ293392A3 (en) | 1993-12-15 |
| FI924277A (fi) | 1993-03-25 |
| NO923695D0 (no) | 1992-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL296038A1 (en) | Method of obtaining biosynthesis inhibitors effective in respect to biosynthesis of leucotrienes | |
| AR245193A1 (es) | Procedimiento para disminuir, por degradacion enzimatica, el contenido de componentes fosforados en aceites vegetales y animales. | |
| PL296034A2 (en) | Composition exibiting-fgf activity and method of obtaining same | |
| EP0497468A3 (en) | Method of improving signal-to-noise in electropherogram | |
| GB2224734B (en) | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors | |
| PL294309A1 (en) | Method of obtaining novel derivatives of 2-amino-pyrimidincarbonamide-4 | |
| AU1307592A (en) | Improvements in or relating to methods of and/or apparatus for forming joints | |
| PL296809A1 (en) | Method of processing creosolic acid of natural origin | |
| PL302373A1 (en) | Derivatives of substituted imidazobenzoxazin-1-one and method of obtaining them | |
| PL295042A1 (en) | Method of obtaining novel derivatives of 2-piperidinylpyrimidin-4-carboxyamide | |
| PL299871A1 (en) | Method of obtainingenamines in aqueous environment | |
| PL292950A1 (en) | Method of obtaining trialkylogalium | |
| PL289716A1 (en) | Method of obtaining buprenophine | |
| PL292318A1 (en) | Method of obtaining 7-hydroxy-4-methylcoumarin | |
| PL289244A1 (en) | Method of obtaining corrosion inhibitors | |
| PL288866A1 (en) | Method of obtaining 2-nitro-5-phenylthioanilin | |
| PL289736A1 (en) | Method of obtaining hydridocarbonyltristriphenyl-phosphinorhodium | |
| PL276722A2 (en) | Asphalt-tar compositions in particular anticorrosive ones and method of obtaining such compositions | |
| ZA946477B (en) | Morpholine-derivatives their method of preparation and their use as corrosion inhibitors | |
| PL292770A1 (en) | Method of obtaining derivatives of 2-aminobenzothiazole | |
| BG45919A1 (en) | Derivative of benzaldehine and method for its preparation | |
| PL293349A1 (en) | Method of obtaining benzoxzyphenyl derivatives | |
| PL290241A1 (en) | Method of obtaining n-phenylocarbaminic asters | |
| ZA923044B (en) | Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors | |
| PL270582A1 (en) | Method of placing explosiwe in blast-holes |